...
首页> 外文期刊>Current opinion in anaesthesiology >Percutaneous valve interventions.
【24h】

Percutaneous valve interventions.

机译:经皮瓣膜干预。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: Open heart surgery has long been considered the gold standard for treatment of patients with valvular heart disease. Although results are excellent, this technique requires the use of cardiopulmonary bypass and is associated with protracted recovery and attendant risks of open surgery. The field of percutaneous valve interventions has emerged as a closed-chest alternative for all patients, but particularly those who otherwise would be considered too high risk for open surgery. RECENT FINDINGS: Several devices are currently being evaluated in the clinical realm for each heart valve, particularly for the aortic and mitral positions. Early results are promising, but longer follow-up is necessary to determine durability of the procedures. SUMMARY: Although only in its infancy, percutaneous valve therapies offer heart valve interventions without the use of cardiopulmonary bypass. This creates many new possibilities for patients, especially those who are deemed either high risk or inoperable by the usual surgical standards. Newer device iterations and longer term follow-up will be necessary as the field moves forward.
机译:审查目的:长期以来,心脏直视手术一直被认为是治疗瓣膜性心脏病患者的金标准。尽管效果极佳,但该技术需要使用体外循环,并且恢复时间长,并伴有开放手术的风险。经皮瓣膜介入术的领域已成为所有患者的闭胸替代方法,但特别是那些否则将被认为开放手术风险过高的患者。最近的发现:目前正在临床领域中针对每个心脏瓣膜,尤其是主动脉和二尖瓣位置评估几种设备。早期结果令人鼓舞,但需要更长的随访时间来确定手术的持久性。简介:尽管仅在婴儿期,经皮瓣膜疗法可在不使用体外循环的情况下提供心脏瓣膜干预。这为患者创造了许多新的可能性,尤其是那些被常规手术标准认定为高风险或无法手术的患者。随着该领域的发展,将需要更新的设备迭代和更长期的跟踪。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号